コージンバイオ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 化学 | 177A/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2025/12/05 | 日証協 | 91,010株 | -6.18% | 400株 | -96.12% | 126,817株 | -1.48% | 1,600株 | +33.22% |
| 2025/11/28 | 日証協 | 97,010株 | -2.90% | 10,300株 | +9999.99% | 128,717株 | -0.62% | 1,201株 | -45.41% |
| 2025/11/21 | 日証協 | 99,910株 | -19.95% | 100株 | -99.61% | 129,516株 | -6.77% | 2,200株 | -80.87% |
| 2025/11/14 | 日証協 | 124,810株 | +13.76% | 25,500株 | +298.44% | 138,916株 | +5.63% | 11,500株 | +1176.36% |
| 2025/11/07 | 日証協 | 109,710株 | +2.72% | 6,400株 | -57.05% | 131,515株 | 0.00% | 901株 | -82.33% |
| 2025/10/31 | 日証協 | 106,810株 | -1.02% | 14,900株 | +73.26% | 131,515株 | -1.57% | 5,100株 | +142.86% |
| 2025/10/24 | 日証協 | 107,910株 | -0.55% | 8,600株 | -1.15% | 133,615株 | -0.52% | 2,100株 | -67.19% |
| 2025/10/17 | 日証協 | 108,510株 | -1.09% | 8,700株 | -28.69% | 134,315株 | +1.43% | 6,400株 | +82.86% |
| 2025/10/10 | 日証協 | 109,710株 | -8.66% | 12,200株 | -33.70% | 132,415株 | -3.94% | 3,500株 | -77.12% |
| 2025/10/03 | 日証協 | 120,110株 | -0.58% | 18,400株 | +39.39% | 137,840株 | -2.20% | 15,300株 | +512.00% |
| 2025/09/26 | 日証協 | 120,810株 | -5.85% | 13,200株 | -28.26% | 140,940株 | -3.09% | 2,500株 | -56.90% |
| 2025/09/19 | 日証協 | 128,310株 | -0.23% | 18,400株 | -6.65% | 145,440株 | -0.48% | 5,800株 | +26.09% |
| 2025/09/12 | 日証協 | 128,610株 | -10.75% | 19,710株 | -64.87% | 146,140株 | -7.18% | 4,600株 | -89.13% |
| 2025/09/05 | 日証協 | 144,100株 | +52.49% | 56,100株 | +850.85% | 157,440株 | +22.68% | 42,301株 | +471.64% |
| 2025/08/29 | 日証協 | 94,500株 | -7.08% | 5,900株 | -80.00% | 128,339株 | -1.61% | 7,400株 | -4.22% |
| 2025/08/22 | 日証協 | 101,700株 | -13.52% | 29,500株 | +340.30% | 130,439株 | -11.15% | 7,726株 | -46.72% |
| 2025/08/15 | 日証協 | 117,600株 | -10.23% | 6,700株 | 0.00% | 146,814株 | -1.61% | 14,500株 | +2316.67% |
| 2025/08/08 | 日証協 | 131,000株 | -1.36% | 0株 | 0.00% | 149,214株 | -0.73% | 600株 | +20.00% |
| 2025/08/01 | 日証協 | 132,800株 | -4.87% | 0株 | -100.00% | 150,314株 | -2.47% | 500株 | -50.00% |
※株式分割は考慮していませんのでご注意ください。
Page Top